Form 8-K - Current report:
SEC Accession No. 0001104659-23-074068
Filing Date
2023-06-23
Accepted
2023-06-23 09:27:03
Documents
13
Period of Report
2023-06-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319527d1_8k.htm   iXBRL 8-K 40964
2 EXHIBIT 10.1 tm2319527d1_ex10-1.htm EX-10.1 221838
  Complete submission text file 0001104659-23-074068.txt   487069

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mxct-20230622.xsd EX-101.SCH 3224
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mxct-20230622_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mxct-20230622_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319527d1_8k_htm.xml XML 3700
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 231035113
SIC: 8731 Services-Commercial Physical & Biological Research